Indeed, we found that RB1 deletion in mouse and human experimental models of prostate cancer also facilitated lineage plasticity with transformation of prostate adenocarcinoma to neuroendocrine (small cell) variants. This evidence concerns the gene RB1 and prostate carcinoma.